Biopsys in alliance with Oncocath:
This article was originally published in Clinica
Executive Summary
Biopsys Medical has acquired a minority equity stake in Oncocath, the developer of a site-specific radiation delivery system. Biopsys has also been granted exclusive worldwide rights for breast cancer applications of the Oncocath product. The system under development uses a single-use percutaneous balloon device which positions a therapeutic radioisotope directly at the cancer site. Oncocath is a privately-held company in Roswell, Georgia.